Ensayos Clínicos

A phase 3b, randomized, contrtrolled, multicenter study with oral ferric maltol (Feraccru) or intravenous iron (FCM), for the treatment of iron deficiency anemia in subjects with inflamatory bowel disease.

Ficha Técnica

Investigador Principal

EVA IGLESIAS FLORES

Promotor

CLINIPACE GLOBAL LIMITED

ESTADO

CERRADO

DEPARTAMENTO

Aparato Digestivo

Código EudraCT: 2015-002496-26

Número protocolo: ST10-01-304

Fecha Inicio: 2016-04-15

Fecha Fin: 2018-12-31